Logo for Labcorp Holdings Inc

Labcorp Holdings Investor Relations Material

Latest events

Logo for Labcorp Holdings Inc

Q4 2024

Labcorp Holdings
Logo for Labcorp Holdings

Q4 2024

6 Feb, 2025
Logo for Labcorp Holdings

Q3 2024

24 Oct, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Labcorp Holdings Inc

Access all reports
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of tests in its human diagnostic division, which is operated under the name of LabCorp. The Division provides testing and analytical services to the clients in health care industry, pharmaceutical companies, manufacturers, academic institutions and government agencies. Its offerings include anatomic pathology services, such as fine needle aspiration cytology (FNAC), cancer genetics/genomics, oncology focused protein marker testing, genetic counseling, and targeted genomic medicine; clinical chemistry test such as quantitative immunoassays and traditional immunoassays for the detection of infectious diseases; molecular diagnostics; microbiology - includes products for culture identification and antimicrobial sensitivity determination for transplant recipients and suspected infectious disease patients. In addition, the announced plans to acquire Knight Diagnostic Laboratories from New Jersey based Knight Human Capital Management. Laboratory Corporation of America Holdingsin is based in Burlington, North Carolina.